These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 15289348)
1. Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells. Zingg D; Riesterer O; Fabbro D; Glanzmann C; Bodis S; Pruschy M Cancer Res; 2004 Aug; 64(15):5398-406. PubMed ID: 15289348 [TBL] [Abstract][Full Text] [Related]
2. Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response. Tan J; Hallahan DE Cancer Res; 2003 Nov; 63(22):7663-7. PubMed ID: 14633687 [TBL] [Abstract][Full Text] [Related]
3. Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells. Riesterer O; Zingg D; Hummerjohann J; Bodis S; Pruschy M Oncogene; 2004 Jun; 23(26):4624-35. PubMed ID: 15064712 [TBL] [Abstract][Full Text] [Related]
4. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity. Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200 [TBL] [Abstract][Full Text] [Related]
5. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Gao N; Nester RA; Sarkar MA Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414 [TBL] [Abstract][Full Text] [Related]
7. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Montaner S; Sodhi A; Pece S; Mesri EA; Gutkind JS Cancer Res; 2001 Mar; 61(6):2641-8. PubMed ID: 11289142 [TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233 [TBL] [Abstract][Full Text] [Related]
9. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways. Choi JA; Park MT; Kang CM; Um HD; Bae S; Lee KH; Kim TH; Kim JH; Cho CK; Lee YS; Chung HY; Lee SJ Oncogene; 2004 Jan; 23(1):9-20. PubMed ID: 14712206 [TBL] [Abstract][Full Text] [Related]
10. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Adya R; Tan BK; Punn A; Chen J; Randeva HS Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986 [TBL] [Abstract][Full Text] [Related]
11. Copper ions strongly activate the phosphoinositide-3-kinase/Akt pathway independent of the generation of reactive oxygen species. Ostrakhovitch EA; Lordnejad MR; Schliess F; Sies H; Klotz LO Arch Biochem Biophys; 2002 Jan; 397(2):232-9. PubMed ID: 11795876 [TBL] [Abstract][Full Text] [Related]
12. Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity. Toulany M; Baumann M; Rodemann HP Mol Cancer Res; 2007 Aug; 5(8):863-72. PubMed ID: 17699110 [TBL] [Abstract][Full Text] [Related]
13. Betacellulin induces angiogenesis through activation of mitogen-activated protein kinase and phosphatidylinositol 3'-kinase in endothelial cell. Kim HS; Shin HS; Kwak HJ; Cho CH; Lee CO; Koh GY FASEB J; 2003 Feb; 17(2):318-20. PubMed ID: 12475887 [TBL] [Abstract][Full Text] [Related]
14. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. Wang Z; Jiang C; Ganther H; Lü J Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Chen EY; Mazure NM; Cooper JA; Giaccia AJ Cancer Res; 2001 Mar; 61(6):2429-33. PubMed ID: 11289110 [TBL] [Abstract][Full Text] [Related]
16. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway. Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921 [TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. Zhang X; Groopman JE; Wang JF J Cell Physiol; 2005 Jan; 202(1):205-14. PubMed ID: 15389531 [TBL] [Abstract][Full Text] [Related]
18. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948 [TBL] [Abstract][Full Text] [Related]
19. RANKL regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Kim HH; Shin HS; Kwak HJ; Ahn KY; Kim JH; Lee HJ; Lee MS; Lee ZH; Koh GY FASEB J; 2003 Nov; 17(14):2163-5. PubMed ID: 14500543 [TBL] [Abstract][Full Text] [Related]
20. Prolactin induces c-Myc expression and cell survival through activation of Src/Akt pathway in lymphoid cells. Domínguez-Cáceres MA; García-Martínez JM; Calcabrini A; González L; Porque PG; León J; Martín-Pérez J Oncogene; 2004 Sep; 23(44):7378-90. PubMed ID: 15286700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]